Asterias Biotherapeutics Inc Logo Image

Asterias Biotherapeutics Inc

Asterias Biotherapeutics Inc Banner Image

Most Recent Annual Report

2017 Annual Report

Asterias Biotherapeutics Inc


Asterias Biotherapeutics Inc has reached its limit for free report views.

Asterias Biotherapeutics Inc does not currently have any hardcopy reports on Click the button below to request a report when hardcopies become available.

Archived Annual Reports

About Asterias Biotherapeutics Inc

Based in Fremont, California

Asterias Biotherapeutics, Inc., a biotechnology company, focuses on the emerging field of regenerative medicines. It is developing pluripotent stem-cell therapeutic products in the areas of neurology and oncology. The company’s product candidates include AST-OPC1, which is in Phase I/IIa clinical trial for the treatment of spinal cord injury, multiple sclerosis, and stroke; and AST-VAC2, the allogeneic dendritic cells loaded with telomerase antigen for the treatment of non-small cell lung cancer, as well as multiple cancer types, antigens, and infectious diseases. It is also developing AST-VAC1 for the treatment of prostate cancer and acute myelogenous leukemia.

NYSE (See More NYSE Companies)
Biotechnology (See More Biotechnology Companies)
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol